oxyTOCIN 30 Units/500 mL — Class III drug recall D-1544-2022
Terminated recall by QuVa Pharma, Inc., reported 2022-10-05, distributed nationwide. Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) inste
| Recall number | D-1544-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | QuVa Pharma, Inc., Bloomsbury, NJ, United States |
| Recall initiated | 2022-09-20 |
| Classified | 2022-09-26 |
| Reported by FDA | 2022-10-05 |
| Terminated | 2023-02-08 |
| Distributed | Nationwide (US) |
| Quantity | 1,994 bags |
| NDC | 70092-1068-07 |
| Lot numbers | 30027403 |
| Expiration dates | 2022-11-14 |
Product
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV Use, High Alert, This is a Compounded Product for Institutional or Office Use Only, Not for Resale, QuVa PHARMA 519 Route 173, Bloomsbury, NJ 08804, Total volume: 500 mL bag, NDC: 70092-1068-07.
Reason for recall
Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1544-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.